Cardiac Regeneration
Treating coronary artery disease with the power of sound
The CSW Solution
CSW Therapeutics is using the power of focused soundwaves to treat refractory angina, a chronic condition in no-option coronary artery disease patients who suffer from long-lasting symptoms due to ischaemia, affecting:
4.1 million
patients in the US, Europe and Japan [1], causing:
$20B
in annual costs in North America alone [2]
Using recurring & personalized focused soundwave therapy, Neowave Cardio™ use can stimulate myocardial tissue on a cellular level, inducing a regenerative and angiogenic effect, leading to improved ventricular function and quality of life [3].
Our patented Neowave Cardio™ soundwave therapy device aims to:
Investigational Device. Limited by Federal (or United States) Law to Investigational Use
Restore myocardial function and quality of life in a no-option patient group
Reduce readmission rates and cost of patient management
Personalized therapy for optimal therapeutic effect
The Technology
The Neowave Cardio™ device is a next-generation acoustic therapy device, focused on ameliorating anginal symptoms and restoring cardiac function in ischemic heart disease patients.
By employing therapeutic low-intensity acoustic soundwaves, the device aims to catalyze angiogenesis—the natural process of new blood vessel formation—to enhance circulatory function. Cardiac shockwave therapy has been validated in more than 50 studies [4] to:
Reduce angina symptoms
Enhance left ventricular function
Improve exercise capacity and tolerance
By miniaturizing and personalizing therapy, CSW Therapeutics is improving treatment efficacy and therapy compliance, while improving access to care & reducing costs.
NeoWave Cardio™ ultrasound therapy device
Assessment of patient safety and personalized therapy
Adjustable form factor for optimal therapy
Personalized and targeted therapy
Cardiac Extracorporeal Soundwave Therapy utilizes low-intensity acoustic soundwaves, functioning as gentle “wake-up calls” to propel the body’s inherent regenerative processes. These soundwaves induce a mechanical disturbance within the cells, much like a tap on the shoulder, encouraging cellular activation.
Learn More
About
the Treatment
These cells release specific signalling molecules and initiate internal repair mechanisms, beginning a process known as mechanotransduction, where mechanical inputs are converted into biological reactions.
This cellular activity leads to angiogenesis, reduced inflammation, and enhanced tissue healing [5], through the activation of the body’s natural regenerative powers.
Rentrop Score shows the formation of collateral vessels: Grade 0 no collaterals; grade 1 side branch filling of the recipient artery without filling of the main epicardial artery; grade 2 partial filling of the main epicardial recipent artery; and grade 3 complete filling of the main epicardial recipient artery [6].
our partners
Want to learn more?Contact us.
CSW Therapeutics AB
106 31 Stockholm, Sweden